Ceresetto, José, and F Bottaro. “Idarucizumab: Reversal Agent for dabigatrán”. Journal of Hematology 22, no. 3 (January 21, 2019): 315–321. Accessed October 1, 2026. https://mail.revistahematologia.com.ar/index.php/Revista/article/view/46.